Patexia, Inc., an intellectual property company and IP professionals network, has named Nelson Mullins Riley & Scarborough LLP among the top 100 most active law firms in biotech in its 2022 Patent Prosecution Intelligence Report. The rankings cover a five-year period from January 2017 through December 2021 and note that the firm prosecuted 284 biotech patents in that time frame.

The report provides various statistics, revenue data, expenses, and comprehensive analysis and rankings of all stakeholders in patent prosecution, including attorneys and agents. Rankings are determined based on patent statistics, best patent prosecution practices, activity of companies and law firms, and analysis of technology centers and art units.

The Nelson Mullins patent team includes patent attorneys, paralegals, and docketing staff who provide a wide range of patent services to a large base of domestic and international corporations. Our attorneys are registered to practice before the U.S. Patent and Trademark Office and hold technical degrees in a wide range of disciplines: chemical engineering, chemistry, biotechnology, mechanical engineering, textile technology, electrical engineering, physics, among others. The team has a depth of experience in patent application preparation, filing, prosecution, opinions, client counseling, patent portfolio management, and post-grant practice and knowledge of U.S. and foreign patent policies, treaties, and regulations.

According to the organization, Patexia was founded in 2010 to bring efficiency and transparency to intellectual property by leveraging the power of data, technology, and experts, The company provides  IP services in lateral opportunity and recruiting, IP analytics and insights, expert services, and patent due diligence. Click here for more information.

Established in 1897, Nelson Mullins is an Am Law 100 firm of more than 930 attorneys and government relations professionals with offices in 15 states and Washington, D.C. For more information on the firm, go to www.nelsonmullins.com.